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The opportunistic pathogen Burkholderia cenocepa-
cia expresses several soluble lectins, among them
BC2L-C.This lectinexhibits twodomains:aC-terminal
domain with high sequence similarity to the recently
described calcium-dependent mannose-binding lec-
tin BC2L-A, and an N-terminal domain of 156 amino
acids without similarity to any known protein. The re-
combinant N-terminal BC2L-C domain is a new lectin
with specificity for fucosylated human histo-blood
group epitopes H-type 1, Lewis b, and Lewis Y, as
determined by glycan array and isothermal titration
calorimetry.Methylselenofucosidewasusedas ligand
to solve the crystal structure of theN-terminal BC2L-C
domain. Additional molecular modeling studies ratio-
nalized the preference for Lewis epitopes. The struc-
ture reveals a trimeric jellyroll arrangement with
striking similarity to TNF-like proteins, and to BclA,
the spore protein from Bacillus anthracis which may
play an important role in bioadhesion of anthrax
spores in human lungs.
INTRODUCTION
Burkholderia cenocepacia is a Gram-negative bacterium
belonging to the Burkholderia cepacia complex (BCC), a collec-
tion of genetically distinct but phenotypically similar bacteria that
are divided into at least ten species (Mahenthiralingam et al.,
2008). BCC strains are common in the environment and can be
isolated from a variety of sources including water, soil, and vege-
tation. They are known as pathogens of onion and banana and
colonizers of the rhizospheres of many plant species (Jacobs
et al., 2008). This bacterium is also characterized as an opportu-
nistic pathogen for patients suffering from cystic fibrosis (Butler
et al., 1995) and chronic granulomatous diseases (Winkelstein
et al., 2000). The most serious complication is the so-called Ce-
pacia syndrome (Isles et al., 1984), a rapid pulmonary disorder
often leading to respiratory failure with fatal consequences.Structure 18,The majority of isolates recovered from cystic fibrosis patients
belong to B. cepacia genomovar III, recently renamed B. ceno-
cepacia (Courtney et al., 2004; Vandamme et al., 2003).
Opportunistic bacteria, like other pathogenic microorganisms,
often employ lectins to target host glycoconjugates for recogni-
tion and adhesion processes (Imberty and Varrot, 2008; Sharon,
1996). We recently characterized a dimeric soluble lectin,
BC2L-A, from B. cenocepacia strain J2315 (Lameignere et al.,
2008). BC2L-A is a 129 amino acid protein that displays strict
specificity for mannose and a-mannoside-containing oligosac-
charides and requires two calcium ions in the binding site. This
direct coordination to calcium provides high affinity for carbohy-
drate ligands (Kd of 5 mM for mannose). BC2L-A displays
sequence and fold similarity with PA-IIL (LecB), a soluble
fucose/mannose-binding lectin from Pseudomonas aeruginosa
that has recently been the subject of extensive structure/function
studies (Loris et al., 2003; Mitchell et al., 2002, 2005; Perret et al.,
2005; Sabin et al., 2006) and has been demonstrated to be
directly involved in the pathogenicity of P. aeruginosa in a mice
infection model (Chemani et al., 2009).
Genome analysis ofB. cenocepacia strain J2315 indicated the
presence of two other genes coding for PA-IIL-like proteins on
chromosome 2 (in addition to the one coding for BC2L-A) with
sizes of 732 and 816 bp (Lameignere et al., 2008). A third one
(877 bp) could be identified on chromosome 3 of B. cepacia
R18194-1TCC17660. The three putative proteins are referred to
as BC2L-B (244 amino acids), BC2L-C (272 aa), and BC2L-D
(289 aa). All three polypeptides display a PA-IIL-like domain at
the C-terminal domain and an additional domain (120–160 amino
acids) at the N-terminal domain. The three N-terminal domains
have no similarities to other proteins or to each other.
In the framework of a large project aiming at deciphering the
strategies used by opportunistic bacteria to recognize the
glycans that are present on host epithelial cells, we are conduct-
ing a systematic study on the soluble lectins of B. cenocepacia
and their associated domains. In the present work, we cloned
and purified the recombinant N-terminal domain from BC2L-C
(BC2L-C-nt) and demonstrated its fucose-binding activity with
high affinity for H-type and Lewis human histo-blood group
epitopes. The crystal structure revealed a trimeric assembly
that has not been observed for lectins but that is highly similar59–72, January 13, 2010 ª2010 Elsevier Ltd All rights reserved 59
Figure 1. SPR Sensorgrams Displaying
Binding of BC2L-C-Nt on Sugar-Immobi-
lized Chips
(A) Interaction of BC2L-C-nt with a chip surface
covered with PAA polymer with linked fucose
(top), mixed fucose/mannose (middle), and
mannose (bottom).
(B) Same experiments after preincubating BC2L-
C-nt with 20 mM L-fucose.
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A Bacterial Lectin with a TNF-like Foldto tumor necrosis factor (TNF) -a or C1q complement proteins.
The BC2L-C lectin is therefore a new superlectin with two
different carbohydrate-binding domains.
RESULTS
BC2L-C-Nt Characterization
BC2L-C was identified as a PA-IIL-like lectin in the translated
genome of B. cenocepacia strain J2315 (NCBI-GI 206562055)
(Lameignere et al., 2008). The sequence consists of 272 amino
acids (including an initial methionine). Similarity with P. aerugi-
nosa PA-IIL is detected at the C-terminal region (48% identity
for 115 amino acids). The N-terminal domain consists of 156
amino acids separated from the PA-IIL-like domain by a 28 amino
acid linker rich in glycine and serine (TAAPSSQGSGNQ-
GAETGGTGAGNIGGGG). The gene is present on chromosome
2 of all B. cenocepacia strains that have been sequenced.
A search in other bacterial genomes identifies the presence of
this particular domain in B. species, another member of the
BCC, with 92% identity for the N-terminal domain and 83% iden-
tity for the whole protein (hypothetical protein Bcep18194_B2934
[Burkholderia sp. 383], NCBI-GI 78063781). Only one protein
from another bacterium displays similarity with BC2L-C-nt. In
the recently sequenced genome of the insect pathogen Photo-
rhabdus luminescens (Duchaud et al., 2003), the gene 2804253
codes for a small hypothetical protein of 140 amino acids that
displays 59% identity with the BC2L-C-nt domain.
The expression of native BC2L-C in B. cenocepacia strain
J2315 was tested under different growth conditions, including
cultivation on minimal and rich media in the presence and
absence of iron and various sugars, followed by purification on
a mannose-agarose column following a procedure previously
described (Lameignere et al., 2008). Four days of cultivation on
rich medium in the presence of D-mannose resulted in the
distinct appearance of a band with the expected size of
28 kDa on SDS-PAGE. The band was excised from the gel and
analyzed by MS. The results of a search using MASCOT (Matrix
Science) based on the MALDI-MS and LC-MS/MS analyses of
the prepared tryptic digest against the NCBI database indicated
the presence of B. cenocepacia AU1054 (NCBI-GI 107027320),
which is a BC2L-C ortholog from another B. cenocepacia strain.
Highly comparable results were obtained with a search against
a local database containing data from B. cenocepacia strain
J2315 (data from The Sanger Institute, which are not included
in the NCBI sequence database). This search found five protein60 Structure 18, 59–72, January 13, 2010 ª2010 Elsevier Ltd All rightfragments matching the protein sequence with a final score of
139 and a sequence coverage of 28%.
Production and Analysis of the Recombinant N-Terminal
Domain of BC2L-C
BC2L-C-nt was produced in a recombinant form in Escherichia
coli in order to study its structure and function. In addition to
the sequence coding for the 156 first amino acids of BC2L-C,
a histidine tag was attached to the C-terminal end, resulting in
a 187 amino acid polypeptide (19.26 kDa). The total yield of the
obtained protein was as much as 20 mg/L of culture medium
(see Figures S1 and S2 available online).
The recombinant BC2L-C-nt domain was analyzed by size-
exclusion chromatography on a Bio-Silect SEC 250-5 (Bio-Rad)
column using an FPLC system (A¨CTA; GE Healthcare). The
protein eluted as a peak in the elution volume of 8.33 ml corre-
sponding to a molecular weight of56.4 kDa as determined using
a gel-filtration standard calibration curve (Bio-Rad) (Figure S3).
This value corresponds closely to the formation of a trimer in solu-
tion with a theoretical molecular weight of 57.8 kDa.
Lectin Activity of BC2L-C-Nt
In the absence of any similarity to proteins with known function,
the first hypothesis was to envisage a lectin activity for the BC2L-
C-nt domain. A surface plasmon resonance (SPR) study was
performed by immobilizing different biotin-PAA-monosaccha-
rides on avidin chips. The four available channels presented
a-L-fucose, a-D-mannose, b-D-galactose, and a 1/1 mixture of
a-L-fucose/a-D-mannose residues. Only binding to the channel
presenting fucose alone or a fucose/mannose mixture was
observed (Figure 1). The BC2L-C-nt domain can therefore be
defined as a new fucose-binding lectin.
In order to specify the fucosylated human epitopes recognized
by BC2L-C-nt, the lectin activity was analyzed by a glycan array
(Consortium for Functional Analysis), which allows for screening
a broad spectrum of mammalian glycans. The Printed Array,
version 3.2, containing 377 glycans was used. N-terminal
BC2L-C domain has a strict specificity for fucosylated oligosac-
charides (Figure 2; Table S1), but it was noted that short frag-
ments such as monosaccharides (a-L-fucose) (10 and 11) and
disaccharides (aFuc1-2Gal, aFuc1-3GlcNAc, aFuc1-4GlcNAc)
(73–76) are not efficient ligands.
The smallest high-affinity epitopes are the H-type 1 trisaccha-
ride (aFuc1-2bGal1-3bGlcNAc 54) and H-type 3 trisaccharide
(aFuc1-2bGal1-3aGalNAc 57), corresponding to two forms ofs reserved
Figure 2. Glycan Array of BC2L-C-Nt Labeled with Alexa Fluor Dye
H-type 1-containing glycans, red; H-type 2, dark blue; H-type 3 and H-type 4, violet; Lea, orange; Leb, yellow; LeX, light blue; LeY, cyan; and blood group B, green.
The omitted area corresponds to a series of glycans with no significant labeling. Complete results including a comprehensive oligosaccharide list (Printed Array
version 3.2) are available from the Consortium of Functional Glycomics (http://www.functionalglycomics.org) and in Supplemental Information.
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ciently to H-type 1-containing glycans, such as the biantennary
glycan presenting two such epitopes (356), and to the Lewis
b branched oligosaccharide (LeB: aFuc1-2bGal1-3[aFuc1-
4]bGlcNAc) (56 and 371), but not to blood group A and B
epitopes with the same type 1 core. In the type 2 series, the
trisaccharide H-type 2 aFuc1-2bGal1-4bGlcNAc (70 and 71) is
weakly bound but the branched tetrasaccharide, Lewis Y (LeY:
aFuc1-2bGal1-4[aFuc1-3]bGlcNAc) (64–67) is a high-affinity
ligand. The BC2L-C-nt binding affinity for other fucosylated
structures, such as Lewis a (Lea: bGal1-3[aFuc1-4]bGlcNAc)
and Lewis X (LeX: bGal1-4[aFuc1-3]bGlcNAc) and their sialylated
forms SLea and SLeX, is significantly lower than for the aFuc1-
2Gal-containing glycans. aFuc1-6bGlcNAc, often present on
the core disaccharide of animal N-glycans, is not recognized
by BC2L-C-nt.
Affinity Analysis
The binding of BC2L-C-nt to human glycosidic epitopes was
further characterized by titration microcalorimetry to determine
the association constants and thermodynamic characteristics
of the interaction. Several fucosylated compounds such asStructure 18,methyl-a-L-fucoside (aMeFuc), human blood group O antigens
H-type 1 and H-type 2, and Lewis antigens Lea, Leb, LeX, and
LeY were used in the assay. The monosaccharide derivative
methyl-a-D-mannoside (aMeMan) was included for comparison.
All thermograms started with strongly exothermic peaks, char-
acteristic of enthalpy-driven interactions, followed by peaks
decreasing in height while saturation was achieved (Figures 3A
and 3B). The mannoside aMeMan does not display any binding
activity (Figure 3A0).
All thermodynamic characteristics of the interaction are
summarized in Table 1. When the affinity was strong enough to
obtain a sigmoidal curve for the titration process (Figure 3B),
the stoichiometry of binding could be determined with values
close to unity, indicating one sugar binding site per monomer.
This value was fixed for low-affinity ligands. The BC2L-C-nt
domain binds to monosaccharide derivative aMeFuc in solution
with affinity in the millimolar range (Kd = 2.7 mM), as usually
observed for lectin/monosaccharide interaction. The H-type 1
trisaccharide has a strong affinity (Kd = 77 mM) in agreement
with the glycan array data, whereas the H-type 2 trisaccharide
interaction is about 20 times weaker, with affinity in the millimolar
range. Lewis Y appears to be the best ligand in solution, with a Kd59–72, January 13, 2010 ª2010 Elsevier Ltd All rights reserved 61
Figure 3. Titration Microcalorimetry of
BC2L-C-Nt by Different Carbohydrates
(A) Titration curve at 25C of BC2L-C-nt (286 mM)
by aMeFuc (49.3 mM) from 29 automatic injections
of 10 ml of sugar added every 300 s to BC2L-C-nt-
containing cells.
(A0) Titration by aMeMan (50.2 mM) using the same
conditions but with 17 injections.
(B) Titration curve of BC2L-C-nt (414 mM) by Lewis
Y (9.827 mM from 39 automatic injections of 0.8 ml
of sugar added every 100 s to BC2L-C-containing
cells. Proteins and saccharides were prepared in
20 mM Tris-HCl, 20 mM NaCl, 5 mM CaCl2 (pH
7.5). For all panels, lower plots show the total
heat released as a function of total ligand concen-
tration. The solid line represents the best least-
squares fit.
(C) Superimposition of integrated heat plots for all
tested oligosaccharides.
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does not perform so well in solution, with a Kd value of 213 mM.
The other Lewis antigens, Lea and LeX, are in an intermediate
range.
Analysis of the thermodynamic contributions suggests two
different binding modes. All observed interactions display strong
favorable enthalpy contributions. Most complexes also display
an unfavorable entropy contribution that partly compensates
the strong enthalpy of binding. However, the oligosaccharides
containing the aFuc1-2bGal1-3bGlcNAc fragment (H-type 1
and Lewis b) have a neutral or slightly favorable change in
entropy TDS upon binding. This clearly appears in Figure 3C,
where a comparison of titration curves in a log scale of molar
ratio versus enthalpy is displayed illustrating the difference in
enthalpy contribution for the different oligosaccharides.62 Structure 18, 59–72, January 13, 2010 ª2010 Elsevier Ltd All rights reservedDetermination of the BC2L-C-Nt
Crystal Structure
Because the selenomethionine N-ter-
minal BC2L-C domain (SeMet-BC2L-
C-nt) contains only two methionine resi-
dues, anomalous phasing power was
increased by crystallizing in the presence
of methylseleno-a-L-fucopyranoside
(aMeSeFuc) synthesized as previously
described (Kostlanova´ et al., 2005). The
complex crystallized in space group
P212121 with unit cell parameters (a =
43.10 A˚, b = 76.73 A˚, c = 103.26 A˚) with
three monomers in the asymmetric unit.
The crystal structure was solved with the
multiple anomalous dispersion method
and refined at 1.42 A˚ resolution. Data
collection and refinement statistics are
shown in Table 2.
The final model comprises 134, 130,
and 131 amino acids per subunits A, B,
and C, respectively, as well as 3 mono-
saccharides and 513 water molecules.
Except for the C-terminal part of eachchain that corresponds to the linker region (20 amino acids)
and the tag (30 amino acids), the electron density is very well
defined for the three monomers. The linker sequence is rich in
serine and glycine and therefore is expected to be flexible in
solution. One solvent molecule was unambiguously identified
as a bromide ion coming from the crystallization buffer.
Overall Structure of BC2L-C-Nt
The BC2L-C-nt domain adopts a compact jellyroll architecture
composed of 11 b strands and a short helix. The b strands are
connected following a Greek-key topology in the sequential
order A, A00, B, C, C0, D, E, F, G, G0, and H (the nomenclature is
the one previously reported for TNF-like proteins [Rety et al.,
2005], as discussed below), resulting in two four-stranded
b sheets that form the two sides of the jellyroll fold. The remaining
Table 1. Thermodynamics of Binding for Saccharides Interacting with the BC2L-C-Nt Domain Determined from ITC Experiments
Ligand n Ka (10
3 M1) Kd (mM) DG (kJ/mol) DH (kJ/mol) TDS (kJ/mol)
Lewis Y 0.98 ± 0.03 18.60 ± 1.00 53.9 ± 2.9 24.4 ± 0.2 34.9 ± 0.3 10.54
H-type 1 0.93 ± 0.02 12.9 ± 0.3 77.2 ± 1.5 23.5 ± 0.2 23.0 ± 0.3 0.46
Lewis a 0.72 ± 0.02 7.6 ± 0.1 132.1 ± 1.2 22.1 ± 0.1 48.11 ± 0.3 26.0
Lewis X 0.73 ± 0.04 5.1 ± 0.1 196 ± 5 21.2 ± 0.2 38.7 ± 0.1 17.5
Lewis b 1.11 ± 0.09 4.7 ± 0.3 213 ± 13 21 ± 0.2 19.8 ± 0.1 1.15
H-type 2 1a 0.80 1236 16.60 24.92 8.3
a-Me-L-Fuc 1a 0.37 ± 0.0 2700 ± 7 14.67 ± 0.01 20.9 ± 0.1 6.2
a-Me-D-Man No interaction
All values are averages of at least two independent measurements. In the case of blood group H-type 2 trisaccharides, parameters result from unique
measurements.
a Fixed during the fitting procedure.
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the top of the molecule. The N and C termini are close to each
other and the C terminus points toward the solvent (Figure 4).
The three BC2L-C-nt monomers in the asymmetric unit are
related by a noncrystallographic three-fold axis and form
a compact trimer of 45 A˚ in diameter. The three subunits are
almost identical, with some variability only in loops B/ C and
F / G, showing somewhat higher B factors in the C subunit.
These loops are solvent exposed and are not involved in oligo-
merization nor in sugar recognition. The trimer associates
through the internal b sheet (strands AHCF) that is almost com-
pletely buried and flanks a central amphipathic tunnel (average
diameter 5 A˚) filled with a few ordered solvent molecules. The
loop connecting strands E and F interacts with the same loop
on the two adjacent monomers, thus forming the upper aperture
of the central cavity. The contact area between the two mono-
mers involves 15 hydrogen bonds and 9 hydrophobic contacts
(Table S2) and has a surface area of about 950 A˚2 as calculated
with PISA (Krissinel and Henrick, 2007).
A search for similar folds in structural databases classified
BC2L-C-nt as a member of the TNF-like family of proteins,
despite the absence of sequence similarity. The Dali server
(Holm et al., 2008) gives a strong correlation (Z score > 10)
with ectodysplasin-A (EDA; Protein Data Bank [PDB] ID code
1RJ8, Z score 10.8, rmsd 2.2 A˚, 110 residues aligned) (Hymowitz
et al., 2003), the spore protein BclA (PDB ID code 2Z5W, Z
score 10.2, rmsd 2.3 A˚, 106 residues aligned) (Rety et al.,
2005), and the complement protein C1q (PDB ID code 1PK6, Z
score 10, rmsd 2.3 A˚, 105 residues aligned) (Gaboriaud et al.,
2003).
Comparison of BC2L-C-nt to EDA and BclA, a spore protein
from Bacillus anthracis, is shown in Figure 4. The main difference
between BC2L-C-nt and those proteins is the absence of
b strands A0 and B0. Other original features of BC2L-C-nt are
the additional C0 strand and the short helix between strands B
and C. Overall, the BC2L-C structure looks more elongated
than BclA or EDA, with longer loops, in particular the one con-
necting strands E and F. The similarity of BC2L-C-nt to other
TNF-like proteins is conserved in the quaternary structure
because TNF-like proteins form trimers. Although very compact,
the BC2L-C-nt trimer is less globular than the others (45 A˚ diam-
eter in contrast to 50 A˚ of BclA and EDA), showing a more
pronounced toroidal shape. However, the oligomerizationStructure 18,mode is the same and the central cavity has a very similar diam-
eter in the three proteins.
A Novel Fucose Binding Site
Clear electron density corresponding to one aMeSeFuc ligand
could be identified at each interface between two adjacent
monomers (Figure 5A). The mode of binding for the sugar is iden-
tical in the three binding sites, and only the one located between
chains A and C is described in Figure 5; contacts are listed in
Table S3. This binding site is formed on one side by monomer
C, which contributes by residues of the E b strand, and by
Arg111, which is located on the loop connecting G to G0. Fucose
hydroxyl groups O2 and O3 form hydrogen bonds with atoms
NH1 and NH2 of Arg111 and with the side-chain oxygen of
Thr74. On the adjacent monomer (chain A), the sugar sits at
the end of the loop connecting E to F. Hydroxyl O4 forms
a hydrogen bond with the main-chain O atom of Thr83 and
also interacts with nitrogen NE of the side chain of Arg85. This
arginine has a crucial role, because the nitrogen NH2 forms
a hydrogen bond with the ring oxygen O5. The cooperative inter-
action NE-O4 and NH2-O5 is possible only for carbohydrates
with configurations presenting an axial hydroxyl group at carbon
4, therefore selecting for the L-galacto configuration of fucose
(Figure 5C). The methyl group C6 is involved in a hydrophobic
contact with the ring of Tyr48. Two water molecules, which are
conserved in the three binding sites, play an important bridging
role between the sugar and the protein. Water OW1 interacts
with the fucose O2 group and with the ring hydroxyl group of
Tyr58 of chain C. The water molecule OW2 appears to be partic-
ularly strongly bound because it is almost buried by the fucose,
with hydrogen bonding to O3 of the sugar, to the main-chain
oxygen of Tyr75 (chain C), and to the hydroxyl of Ser82 (chain
A). The methylseleno group does not make any contacts, and
points toward the solvent in a way that would allow for longer
terminal fucose-containing oligosaccharides to be recognized
by the lectin.
Prediction of Structural Interaction between BC2L-C-Nt
and Fucosylated Human Histo-Blood Group
Oligosaccharides
As determined above, the affinity between BC2L-C-nt and
fucose is rather weak but the values increase dramatically for
some of the fucosylated epitopes of the ABO and Lewis systems.59–72, January 13, 2010 ª2010 Elsevier Ltd All rights reserved 63
Table 2. Data Collection, Phasing, and Refinement Statistics
Peak Inflection Remote
Data Collection
Beamline ID14-4
Unit cell (A˚) a = 43.10, b = 76.73, c = 103.26
Space group P212121
Wavelength (A˚) 0.9795 0.9796 0.9755
Resolution limit (A˚) 39.71–1.43 (1.51–1.43)a 39.72–1.43 (1.51–1.43)a 39.72–1.42 (1.50–1.42)a
Total observations 245,999 245,884 249,163
Unique reflections 63,103 (8,729) 63,053 (8,726) 63,845 (8,900)
Completeness 99.2 (95.3) 99.2 (95.3) 99.3 (96.3)
Anomalous completeness 94.4 (76.6) 94.4 (76.4) 94.6 (77.4)
Multiplicity 3.9 (3.2) 3.9 (3.2) 3.9 (3.2)
Anomalous multiplicity 2.0 (1.8) 2.0 (1.8) 2.0 (1.8)
< I >/< sI > 13.3 (2.8) 12.1 (2.6) 10.8 (1.9)
Rmerge (%)
b 4.7 (27.7) 5.1 (29.9) 4.4 (28.9)
Wilson B factor (A˚2) 10.01 10.14 9.99
Refinement
Rcryst
c 13.1
Rfree 16.6
Rmsd bonds (A˚) 0.012
Rmsd angles () 1.513
Ramachandran outliers 0
Protein atoms 3016
Water atoms 513
Other atoms 37
Overall B factors
Main chains 8.9
Side chains 10.3
Sugars 8.5
Water atoms 22.7
a Values in parentheses refer to the highest resolution shell.
b Rmerge =
PjI  < I >j/jP< I >j.
c Rcryst = (
PjjFobs – Fcalcjj)/(
PjjFobsjj).
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A Bacterial Lectin with a TNF-like FoldIn the absence of a crystal structure, molecular modeling has
been used to build complexes of BC2L-C-nt with different oligo-
saccharides. In all cases, the fucose has been located in the
primary binding site in the orientation observed in the crystal
structure. The different oligosaccharides have been built using
the lowest-energy conformation previously reported (Imberty
et al., 1995) and the complexes were optimized. Large confor-
mational changes are not expected to occur, because fucosy-
lated histo-blood group oligosaccharides are branched struc-
tures with unusually restricted conformational freedom
(Imberty et al., 1995; Lemieux et al., 1980).
For the ABH(O) oligosaccharides (Figure 6), only one of the
blood group O subtypes, H-type 1 (aFuc1-2bGal1-3GlcNAc),
has been demonstrated to bind with high affinity (Kd = 77 mM),
whereas H-type 2 (aFuc1-2bGal1-4GlcNAc) binds much more
weakly and blood groups A and B (either with type 1 or type 2
backbone) are not recognized. The galactose bearing the fucose
does not interact with the lectin, whereas the GlcNAc residue64 Structure 18, 59–72, January 13, 2010 ª2010 Elsevier Ltd All rightestablishes additional contacts. In the case of H-type 2, these
contacts are limited to one hydrogen bond between O6 and
OH of Ser82. For H-type 1, the N-acetyl group establishes one
hydrogen bond with Ser82 and the methyl group points toward
the hydrophobic patch made by Phe54 and carbon CD of
Arg111, rationalizing the higher affinity of the lectin for this trisac-
charide. Blood group A or B oligosaccharide would not be recog-
nized, because substitution on position O3 of the central galac-
tose would result in a steric conflict with the Tyr58 side chain.
In both Lewis a and Lewis X binding modes, the terminal
galactose establishes a hydrogen bond between O4 and the
hydroxyl group of Ser82, rationalizing the strong affinity of these
trisaccharides for BC2L-C-nt. The Lewis b and Lewis Y tetrasac-
charides carry two fucose residues, and they can therefore
interact in two different ways with the lectin, either with the
fucose linked to position 2 of galactose in the primary binding
site as for H-type trisaccharides (mode F2) or with the fucose
linked to position 3 or 4 of GlcNAc as for Lewis trisaccharidess reserved
Figure 4. Ribbon Representation of theMonomer and Trimer of BC2L-C-Nt in the Crystal Structure and Comparison with Other Structures of
the TNF Family
EDA-1 (PDB ID code 1RJ7) and BclA (PDB ID code 1WCK). In the representation of monomers, the conserved jellyroll is colored in red. The bound fucose deriv-
ative is represented by spheres.
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A Bacterial Lectin with a TNF-like Fold(mode F3/4). Both binding modes result in additional contact
between the external fucose and the protein surface, with one
or two hydrogen bonds involving the hydroxyl group of Tyr58.
The modeling data were helpful in rationalizing the high affinity
of BC2L-C-nt for H-type and Lewis oligosaccharides. However,Structure 18,attempts to correlate the thermodynamic data with the struc-
tures were not successful, and it is expected that a large part
of the variations observed in enthalpy and entropy contributions
are related to the activity of the water molecules at the protein/
carbohydrate interface.59–72, January 13, 2010 ª2010 Elsevier Ltd All rights reserved 65
Figure 5. Binding Site between Subunits A and C of the Crystal Structure of SeMet-BC2L-C-Nt Complexed with aMeSeFuc
(A) 2Fo  Fc electron density map contoured at 1.0 s together with the protein surface and the conserved water molecules represented by red dots. Subunit A,
pink; subunit C, cyan.
(B) Details of the binding site with hydrogen bonds represented as dashed lines.
(C) Details of the interaction between aMeSeFuc and Arg85.
(D) Alignment of BC2L-C-nt with hypothetical protein plu4240 from P. luminescens with the b strands indicated above. Amino acids involved in the binding of
fucose to BC2L-C-nt are highlighted according to the monomer they belong to.
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A Bacterial Lectin with a TNF-like FoldDISCUSSION
A Novel Fucose Binding Site with Affinity for Human
Epitopes
The BC2L-C-nt domain, which has no similarity to any known
protein, has been demonstrated to be a new fucose-binding lec-
tin. The binding site presents a large number of hydrogen bonds,
as classically observed in protein/carbohydrate interactions and
hydrophobic interactions involving the methyl group of fucose.
Interestingly, the stronger interaction involves an arginine on
the floor of the binding site and O4 and O5 of fucose
(Figure 5C). This corresponds closely to the binding mode that66 Structure 18, 59–72, January 13, 2010 ª2010 Elsevier Ltd All righthas been seen in the crystal structures of fucose-binding lectins
from the fungusAleuria aurantia (Wimmerova´ et al., 2003) and the
bacterium Ralstonia solanacearum (Kostlanova´ et al., 2005),
although no other similarity could be found. Clearly, the arginine
provides the proper arrangement of nitrogen to bind specifically
to a ring oxygen near an axial hydroxyl group, therefore providing
strong specificity for L-fucose.
Glycan array experiments demonstrated that the binding is
highly selective for fucosylated compounds with no binding to
other glycoconjugates. On the glycan array, blood group O
(H-type 1) is very efficiently bound, as are Lewis Y and Lewis
b tetrasaccharides. The Lewis X and Lewis a structures and theirs reserved
Figure 6. Molecular Modeling of the Interac-
tion between BC2L-C-Nt and Histo-Blood
Group Oligosaccharides
The surfaces are colored cyan for monomer A and
pink for monomer B, except for the amino acids
that are labeled. The glycan carbon atoms are
color coded according to the schematic represen-
tation. The arrows indicate the position of the
reducing end for each oligosaccharide.
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A Bacterial Lectin with a TNF-like Foldsialylated derivatives are less efficient ligands, and blood group
A and B epitopes do not bind. The situation is different in solu-
tion, because isothermal titration calorimetry (ITC) affinity values
are in the same range for all Lewis oligosaccharides. This
apparent discrepancy may arise from differences between
surface assays and solution assays. On the glycan array, as on
cell surfaces, oligosaccharides are fixed to large objects via their
reducing ends. Binding to the Fuc1-2Gal epitope (as in H-type 1
and Lewis Y and Lewis b) allows the reducing end to face
outward to the top of the trimer, in a position compatible for
surface binding. On the other end, binding to the Fuc1-3/
4GlcNAc epitope (as in Lewis X and Lewis a) results in presenting
of the reducing ends out of the cylinder (Figure 7). This presenta-Structure 18, 59–72, January 13, 201tion effect could account for the weak
recognition of Lewis X and Lewis a on
the glycan array.
The TNF-like Fold: A New Lectin
Activity for an Old Fold Family
Although displaying no sequence similar-
ities to known proteins, the fold and
trimeric structure of the BC2L-C-nt
domain show remarkable similarity with
TNF-like domains. This family of globular
bell-shaped trimers contains TNF-a but
also the noncollagenous part of collagen
VIII and X and the globular domain of
ACRP30 and C1q. These proteins are
involved in metabolism, extracellular
matrices, and innate immunity. The struc-
ture with the stronger similarity to BC2L-
C-nt is the extracellular domain of EDA,
which is involved in ectodermal develop-
ment and is considered as rather diver-
gent in the TNF family due to its globular
shape (Hymowitz et al., 2003).
None of the TNF family members have
been reported to bind carbohydrate,
except for the cytokine TNF-a, for which
a lectin-like affinity has been proposed
(Lucas et al., 1994). TNF-a has been
shown to interact with uromodulin,
a glycoprotein from human urine, and
the binding can be blocked by the disac-
charide N,N-diacetylchitobiose (Sher-
blom et al., 1988). However, the 15 amino
acid peptide domain that would beinvolved in this interaction (Marquardt et al., 2007) is functionally
and spatially distinct from the TNF receptor binding sites and
does not correspond spatially to the binding site of BC2L-C-nt.
Recently, the globular domain of BclA, the B. anthracis spore
surface protein, has been demonstrated to be the first nonmam-
malian protein in this fold family (Rety et al., 2005). The protein is
present in the exosporium, which is the outermost layer of the
spore, and is the immunodominant antigen of the spore surface
(Steichen et al., 2003). It consists of a globular domain and
a collagen-like region (Sylvestre et al., 2002). Despite the
absence of sequence similarities, the trimeric domains of these
two bacterial proteins have remarkably similar three-dimensional
structures. BclA has been demonstrated to bind to the lung0 ª2010 Elsevier Ltd All rights reserved 67
Figure 7. Graphic Representation of the Two Possible Modes of Binding of the Lewis Y Tetrasaccharide with the BC2L-C-Nt Trimer
(A) Binding mode F2.
(B) Binding mode F3/4.
The oval shapes schematize the extension of the glycoconjugate bearing the LeY moiety. The same color coding is used as in Figure 6.
Structure
A Bacterial Lectin with a TNF-like Foldalveolar surfactant layer (Rety et al., 2005), but no ligands were
identified.
Trimeric b Sandwich Lectins—Convergence
for Efficient Binding to the Glycan Surface
One advantage of the TNF-like fold is the high stability of the olig-
omer, provided by the interaction between b strands, and the
efficient clustering of the binding sites. Such trimers of b sand-
wiches have been observed in several other lectin structures
(Figure 8). They form in all cases more or less elongated cylinders
with three carbohydrate binding sites located clustered on the
top of the protein and with proper geometries to bind glycocon-
jugates presented in parallel fashion on cell surfaces. Helix
pomatia agglutinin trimer is very similar to BC2L-C-nt, with Gal-
NAc binding sites located at the interface of monomers (Sanchez
et al., 2006). Eel lectin has about the same size, but the fucose
binding sites are located within each monomer (Bianchet et al.,
2002). Some viruses also present protruding trimers of b sand-
wiches on their surfaces, such as the fiber protein of adenovirus
(Burmeister et al., 2004) and the globular head of influenza virus
hemagglutinin (Weis et al., 1990).
CONCLUSIONS
BC2L-C-nt is the first example of a TNF-fold lectin and also the
first b sandwich trimer lectin in bacteria. We could identify
a related sequence only in P. luminescens, a bacterium that lives
in the gut of entomopathogenic nematodes. Because the
P. luminescens sequence has strong similarity (59% identity) to
BC2L-C-nt, and because all amino acids involved in fucose
binding are conserved (Figure 5D), we hypothesized that this
gene codes for a lectin able to bind to fucosylated glycans.68 Structure 18, 59–72, January 13, 2010 ª2010 Elsevier Ltd All rightThe BC2L-C full-length protein consists of the N-terminal
domain, described here, and the C-terminal domain, identified
as a lectin similar to BC2L-A which was previously characterized
(Lameignere et al., 2008). Due to the high sequence similarity, the
C-terminal domain of BC2L-C is predicted to be a mannose-
specific calcium-dependent lectin that associates as a dimer.
Preliminary crystallography and chromatography experiments
confirmed the dimeric state of the C-terminal domain and the
hexameric assembly of the whole BC2L-C protein (unpublished
data). BC2L-C is therefore a ‘‘superlectin,’’ that is, a chimeric
protein consisting of two lectin domains with different
sequences, folds, carbohydrate specificities, and quaternary
arrangements. Determining the overall shape and structure of
the whole superlectin, together with its role in B. cenocepacia
pathogenicity, will therefore be a very challenging project.
EXPERIMENTAL PROCEDURES
Identification of BC2L-CProtein Expression inB. cenocepacia Strain
J2315
Confirmation of BC2L-C expression in wild-type B. cenocepacia was per-
formed as previously described forB. cenocepacia lectin BC2L-A (Lameignere
et al., 2008) using strain J2315, CCM 4899 = LMG 16656, obtained from the
Czech Collection of Microorganisms at Brno. Briefly, cytoplasmic proteins of
B. cenocepacia were purified on a mannose-agarose (Sigma-Aldrich) column
and separated by SDS-PAGE electrophoresis. The band corresponding to the
size of BC2L-C protein was excised and further analyzed by MALDI-MS and
LC-MS/MS.
Construction of Plasmids for Expression of Recombinant
BC2L-C N-Terminal Domain
The gene coding for BC2L-C was synthesized by GenScript with optimization
for expression in E. coli and flanking by NdeI and HindIII sites. The DNA
sequence of the whole gene was cloned into pRSET vector (Invitrogen) ands reserved
Figure 8. Comparison of Crystal Structures of
Different Trimeric Lectins
(A) BC2L-C-nt complexed with aSeMeFuc.
(B) Helix pomatia agglutinin complexed with GalNAc (PDB ID
code 2CCV).
(C) Eel lectin complexed with fucose (PDB ID code 1K12).
(D) Fiber knob of adenovirus complexed with sialylgalactose
(PDB ID code 1UXB).
(E) Head domain of influenza head hemagglutinin complexed
with sialic acid (PDB ID code 5HMG). The carbohydrate
ligands are represented by spheres.
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tin. Initial primers complementary for 31 bp upstream (50-GAAGGAGATATA
CATATGCCGCTGCTGAGCG-30) and downstream (50-TCAAGCTTACCGCC
GCCACCAATATTACC-30 ) introducing NdeI and HindIII restriction sites (under-
lined) to flank the bc2l-c gene were used for preparation of the recombinant
protein. After digestion with NdeI and HindIII, the amplified fragment was in-
serted into the cloning site of pET25(b+) vector (Novagen), resulting in the
plasmid pET25_bc2l-C-Nterm. The construct introduces a His tag at the
C terminus of the recombinant protein. The vector was transformed into
E. coli XL10-GOLD using ampicillin and chloramphenicol for plasmid propaga-
tion. After the expression, the vector pET25_bc2l-C-Nterm was transformed
into E. coli BL21 (DE3) cells (Novagen).Protein Expression and Purification
E. coli BL21 (DE3) cells containing the vector pET25_bc2l-C-Nterm were
cultured in LB medium (Duchefa Biochemie) until the OD600 reached 0.5. After
the addition of 0.5 mM IPTG (isopropyl-b-D-thiogalactopyranoside; Duchefa
Biochemie), cells were cultured for an additional 3 hr at 30C. Cells were har-
vested by centrifugation and resuspended in 20 mM Tris-HCl buffer containing
100 mM NaCl and 100 mM CaCl2 (pH 7.4). Cells were disintegrated by ultra-
sonic vibration, and the soluble fraction was collected by centrifugation at
21,000 3 g at 4C for 30 min. Recombinant N-terminal BC2L-C domain was
purified by affinity chromatography on an Ni-NTA agarose (nickel-nitrilotriace-
tic acid; QIAGEN) column. The soluble protein extract was loaded on a column
preequilibrated with 20 mM Tris (pH 7.4), 150 mM NaCl. After washing, the
protein was eluted with a gradient of 0–250 mM imidazole in the same buffer.
The protein was dialyzed in 10 mM Tris-HCl (pH 7.5), 20 mM NaCl. Protein
purity was assessed by 12% SDS-PAGE and the protein was stained with
Coomassie brilliant blue (Sigma-Aldrich).Preparation and Purification of Selenomethionyl-Modified Protein
For the production of selenomethionine (SeMet) -labeled protein, cells were
cultured in M9 medium in the presence of SeMet (Doublie´, 2007). SeMet incor-
poration was confirmed by in-gel digestion by MALDI-MS/MS and LC-MS/MS.
SeMet-modified protein was purified using the same protocol as described
above for the native protein, with the addition of 0.5 mM TCEP (Tris[2-carbox-
yethyl]phosphine) to the elution buffer.Size-Exclusion Chromatography
The N-terminal BC2L-C domain was analyzed by size-exclusion chromatog-
raphy on a Bio-Silect SEC 250-5 (Bio-Rad) column using an FPLC system
(A¨CTA; GE Healthcare). The analytical column was preequilibrated with
20 mM Tris-HCl (pH 7.4), 300 mM NaCl. The total volume of the sample loaded
on the column was 20 ml, with a flow rate of 0.75 ml/min. Molecular weight was
determined using gel-filtration standards (Bio-Rad).Surface Plasmon Resonance
All SPR experiments were performed using a Biacore 3000 (GE Healthcare)
instrument at 25C with running buffer (HEPES-buffered saline: 10 mM
HEPES, 150 mM NaCl [pH 7.4]) containing 0.005% (v/v) Tween 20 and
a flow rate of 5 ml/min. In the experimental setup, measurements were carried
out simultaneously on four measuring channels using different immobilized
sugars: D-galactose, D-mannose, and L-fucose. The last channel was modi-
fied by a mixture of D-mannose/L-fucose in an equal ratio. The D-galactose-
modified channel was used as a blank control. Biotinylated polyacrylamide
(Biot-PAA) probes bearing sugar moieties (Lectinity) were trapped on a CM5
(Biacore Life Sciences) sensor chip that was coated with streptavidin using
the standard procedure (amine coupling; Biacore Sensor Surface Handbook).
Each Biot-PAA monosaccharide (50 ml at 200 mg/ml) was injected into the
selected channel. Direct binding curves of the BC2L-C-nt lectin to immobilized
sugars were measured over the concentration range 0.06–1 mg/ml. The
protein sample was injected (20 ml; KINJECT) onto the CM5 chip at a flow
rate of 5 ml/min. The inner chip surface was regenerated using 100 mM
EDTA, 50 mM NaOH. Binding interactions were determined by resonance
units over time, and data were evaluated using BIAevaluation Software
(version 4.1).70 Structure 18, 59–72, January 13, 2010 ª2010 Elsevier Ltd All rightGlycan Microarray Analysis
Purified BC2L-C lectin was labeled with Alexa Fluor 488-TFP (Invitrogen) ac-
cording to the manufacturer’s instructions and repurified on a D-salt polyacryl-
amide desalting column (Pierce). Alexa-labeled BC2L-C-nt lectin was used for
glycan array screening with the standard procedure of Core H of the Consor-
tium for Functional Glycomics (Emory University, Atlanta, GA; http://www.
functionalglycomics.org). The screening of the printed glycan microarray
chip (version 3.2 with 377 various glycans from a library of natural and synthetic
glycans) was performed with a concentration of BC2L-C-nt of 200 mg/ml dis-
solved in 20 mM HEPES, 140 mM NaCl, 5 mM CaCl2 (pH 7.4).
Microcalorimetry Experiments
ITC experiments were performed with ITC200 and VP-ITC isothermal titration
calorimeters (Microcal; GE Healthcare). Experiments were carried out at 25C
± 0.1C. Protein was dialyzed against 100 mM Tris (pH 7.5), 0.03 mM CaCl2
and the same buffer was used to prepare the oligosaccharide solutions.
Protein concentrations used for ITC varied from 125 to 420 mM. Injections of
0.8, 5, or 10 ml of ligand solution at various concentrations (from 5.5 to
50.0 mM) were added automatically to the protein solution present in the calo-
rimeter cell while stirring at 1000 rpm. Prior to sample analysis, a control exper-
iment, where the protein sample in the calorimeter cell was substituted by
buffer, was performed, resulting in insignificant heat of dilution. Integrated
heat effects were analyzed by nonlinear regression using a single-site binding
model (Microcal Origin 7). The experimental data fitted to a theoretical titration
curve gave the association constant Ka and the enthalpy of binding DH. The
other thermodynamic parameters such as free energy (DG) and entropy (DS)
were calculated from the equation DG = DH  TDS = RTlnKa, where T is
the absolute temperature and R is the molar gas constant (8.314 J.mol1.K1).
All experiments were performed with c values of 10 < c < 100 (Wiseman et al.,
1989).
Crystallization, Data Collection, and Structure Determination
SeMet-modified protein SeMet-BC2L-C-nt was dialyzed in 5 mM Tris-HCl
buffer (pH 7.5) and concentrated to 15 mg/ml using an Amicon ultrafiltration
device (cutoff 3 kDa; Millipore). Crystallization conditions were screened
with the crystallization screen PACT premier (Molecular Dimensions) using
the Mosquito robot (TTP LabTech). Drops of a protein/precipitant solution
(0.2 ml) were spotted on the crystallization plate (sitting drops) and incubated
at 17C. Initial protein crystals in the form of thin baguettes appeared after
2 weeks in the presence of halide ions, Tris buffer, and PEG 3350. After condi-
tion optimization, crystals suitable for structure determination were obtained
by mixing 2 ml of SeMet-BC2L-C-nt with 2 ml of 0.2 M NaBr, 0.1 M bis-Tris
propane (pH 6.5), 20% PEG 3350. To improve the anomalous signal, the
protein was cocrystallized with a-methylselenofucopyranoside (aMeSeFuc),
whose synthesis has been described previously (Kostlanova´ et al., 2005), at
a final concentration of 25 mM.
Crystals were frozen in liquid nitrogen after soaking them for as short a time
as possible in 20% (v/v) glycerol in precipitant solution. Diffraction data were
collected at the European Synchrotron Radiation Facility, Grenoble, France,
on beamline ID14-4 using a Q315r X-ray detector (ADSC).
Phasing information was obtained from a crystal of SeMet-BC2L-C-nt in
complex with aMeSeFuc. Three different wavelengths (peak, inflection point,
remote) were collected as determined experimentally by an absorption edge
scan. All diffraction images were integrated and scaled using the XDS package
(Kabsch, 1993) and converted into structure factors using the CCP4 program
suite (CCP4, 1994). Phasing was performed by the HKL2MAP suite (Pape and
Schneider, 2004) followed by automated model building using ARP/wARP
(Perrakis et al., 2001). The initial model was completed manually and then
refined against the remote data set using REFMAC (Murshudov et al., 1997)
alternated to manual rebuilding using Coot (Emsley and Cowtan, 2004). The
final model for the N-terminal domain of BC2L-C in complex with aMeSeFuc
was deposited in the PDB database under ID code 2WQ4.
Molecular Modeling
The crystal structure was edited using Sybyl software (TRIPOS), in order to
replace the selenomethionine by a methionine residue. Hydrogen atoms and
partial charges were added and the positions of hydrogen atoms were opti-
mized using the TRIPOS force field (Clark et al., 1989). Oligosaccharidess reserved
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A Bacterial Lectin with a TNF-like Foldwere built using the library of monosaccharides available on the GLYCO3D site
(http://www.cermav.cnrs.fr/glyco3d) and according to the lowest-energy
conformations previously determined (Imberty et al., 1995). Atom types and
charges for oligosaccharides were defined using the PIM parameters devel-
oped for carbohydrates. In all cases, one of the fucose residues of the oligo-
saccharide of interest was superimposed on the fucose in the crystal structure.
Subsequent energy minimizations were performed using the TRIPOS force
field (Clark et al., 1989) with geometric optimization of the sugar and the
side chains of amino acids in the binding site. A distance-dependent dielectric
constant was used in the calculations. Energy minimizations were carried out
using the Powell procedure until a gradient deviation of 0.05 kcal/mol/A˚ was
attained.ACCESSION NUMBERS
The final model for the N-terminal domain of BC2L-C in complex with aMeSe-
Fuc was deposited in the Protein Data Bank under ID code 2WQ4.SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and three tables and can be
found with this article online at doi:10.1016/j.str.2009.10.021.
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